Company
About Us
History
Global Network
Team Culture
AI Solution
Drug Discovery
SM-ARS®
AI-based small-molecule drug discovery
AB-ARS®
AI-based antibody candidate discovery
NEO-ARS®
AI-based neoantigen discovery & vaccine design
Platform
LM-VS™
↗
Language Model-based Virtual Screening
Asset Program
AI-validated ready-to-use drug assets
Science
Pipeline
Drug Discovery Pipelines Powered by Our Proprietary AI Platform
DEEPMATCHER®
Language model for protein-compound interaction prediction
Publications
Publications demonstrating Syntekabio's R&D strength
Business
Co-location
↗
Eco-friendly, cost-effective data center service (ABSC)
Newsroom
Press
Blog
ENG
ENG
KOR
ENG
|
KOR
Company
→
About Us
History
Global Network
Team Culture
AI Solution
→
SM-ARS®
AB-ARS®
NEO-ARS®
LM-VS™
Asset Program
Science
→
Pipeline
DEEPMATCHER®
Publications
Business
→
Co-location
Newsroom
→
Press
Blog
Blog
